Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheng-Tai Lu

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Sensors (Basel, Switzerland)|December 17, 2024
Dynamic Tracking and Real-Time Fall Detection Based on Intelligent Image Analysis with Convolutional Neural NetworkChing-Bang Yao, Cheng-Tai Lu
Journal of Medicinal Chemistry|April 1, 2016
Pyrazolylamine Derivatives Reveal the Conformational Switching between Type I and Type II Binding Modes of Anaplastic Lymphoma Kinase (ALK)Chih-Hsiang Tu, Wen-Hsing Lin, Yi-Hui Peng, et al.
Journal of Medicinal Chemistry|August 2, 2021
Xanthine Derivatives Reveal an Allosteric Binding Site in Methylenetetrahydrofolate Dehydrogenase 2 (MTHFD2)Lung-Chun Lee, Yi-Hui Peng, Hsin-Huei Chang, et al.
European Journal of Medicinal Chemistry|October 28, 2020
Potent and orally active purine-based fetal hemoglobin inducers for treating β-thalassemia and sickle cell diseaseZheng-Sheng Lai, Teng-Kuang Yeh, Yu-Chi Chou, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2012
3-Phenyl-1H-5-pyrazolylamine-based derivatives as potent and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3)John T-A Hsu, Teng-Kuang Yeh, Shih-Chieh Yen, et al.
European Journal of Medicinal Chemistry|June 18, 2015
Identification of a potent 5-phenyl-thiazol-2-ylamine-based inhibitor of FLT3 with activity against drug resistance-conferring point mutationsChiung-Tong Chen, John T-A Hsu, Wen-Hsing Lin, et al.
Bioorganic & Medicinal Chemistry|June 29, 2011
Discovery and evaluation of 3-phenyl-1H-5-pyrazolylamine-based derivatives as potent, selective and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3)Wen-Hsing Lin, Shu-Yi Hsieh, Shih-Chieh Yen, et al.
Bioorganic & Medicinal Chemistry|April 27, 2013
Discovery of 3-phenyl-1H-5-pyrazolylamine derivatives containing a urea pharmacophore as potent and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3)Wen-Hsing Lin, John T-A Hsu, Shu-Yi Hsieh, et al.
Journal of Medicinal Chemistry|November 26, 2024
Development of Potent and Selective Inhibitors of Methylenetetrahydrofolate Dehydrogenase 2 for Targeting Acute Myeloid Leukemia: SAR, Structural Insights, and Biological CharacterizationHsin-Huei Chang, Lung-Chun Lee, Tsu Hsu, et al.
Journal of Medicinal Chemistry|July 2, 2013
Optimization of ligand and lipophilic efficiency to identify an in vivo active furano-pyrimidine Aurora kinase inhibitorHui-Yi Shiao, Mohane Selvaraj Coumar, Chun-Wei Chang, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Sensors (Basel, Switzerland)|December 17, 2024
Dynamic Tracking and Real-Time Fall Detection Based on Intelligent Image Analysis with Convolutional Neural NetworkChing-Bang Yao, Cheng-Tai Lu
Journal of Medicinal Chemistry|April 1, 2016
Pyrazolylamine Derivatives Reveal the Conformational Switching between Type I and Type II Binding Modes of Anaplastic Lymphoma Kinase (ALK)Chih-Hsiang Tu, Wen-Hsing Lin, Yi-Hui Peng, et al.
Journal of Medicinal Chemistry|August 2, 2021
Xanthine Derivatives Reveal an Allosteric Binding Site in Methylenetetrahydrofolate Dehydrogenase 2 (MTHFD2)Lung-Chun Lee, Yi-Hui Peng, Hsin-Huei Chang, et al.
European Journal of Medicinal Chemistry|October 28, 2020
Potent and orally active purine-based fetal hemoglobin inducers for treating β-thalassemia and sickle cell diseaseZheng-Sheng Lai, Teng-Kuang Yeh, Yu-Chi Chou, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2012
3-Phenyl-1H-5-pyrazolylamine-based derivatives as potent and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3)John T-A Hsu, Teng-Kuang Yeh, Shih-Chieh Yen, et al.
European Journal of Medicinal Chemistry|June 18, 2015
Identification of a potent 5-phenyl-thiazol-2-ylamine-based inhibitor of FLT3 with activity against drug resistance-conferring point mutationsChiung-Tong Chen, John T-A Hsu, Wen-Hsing Lin, et al.
Bioorganic & Medicinal Chemistry|June 29, 2011
Discovery and evaluation of 3-phenyl-1H-5-pyrazolylamine-based derivatives as potent, selective and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3)Wen-Hsing Lin, Shu-Yi Hsieh, Shih-Chieh Yen, et al.
Bioorganic & Medicinal Chemistry|April 27, 2013
Discovery of 3-phenyl-1H-5-pyrazolylamine derivatives containing a urea pharmacophore as potent and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3)Wen-Hsing Lin, John T-A Hsu, Shu-Yi Hsieh, et al.
Journal of Medicinal Chemistry|November 26, 2024
Development of Potent and Selective Inhibitors of Methylenetetrahydrofolate Dehydrogenase 2 for Targeting Acute Myeloid Leukemia: SAR, Structural Insights, and Biological CharacterizationHsin-Huei Chang, Lung-Chun Lee, Tsu Hsu, et al.
Journal of Medicinal Chemistry|July 2, 2013
Optimization of ligand and lipophilic efficiency to identify an in vivo active furano-pyrimidine Aurora kinase inhibitorHui-Yi Shiao, Mohane Selvaraj Coumar, Chun-Wei Chang, et al.
Pageof 2